Comment Following the trends (Score 1) 38
Another big tech company cutting, Splunk also was acquisition heavy this year Splunk/Isovalent. So got some extra bodies to cut.
The results were obtained by the conservative-leaning think tank Second Street,
... good sign, it'll be a fair report...
It counted patients who died while waiting for surgery, diagnostic scans and appointments with specialists.
procedures that would improve quality of life in their final years, such as cataract, knee and hip surgery, were also included in the figure.
So the report is close to uninformative. If someone is in poor health, they probably have a bunch of appointments lined up. Them dying on a waiting list isn't surprising information.
Non public care doesn't even solve that. Shoot in America land of the great, my routine eye appointment scheduled 8 months out. Oops, kid was sick that day and have to reschedule, 10 months now.
Sure wait times suck, so pay for more doctors and pay the doctors more to attract people to the role.
Or switch to a private system so that AI can screw others over so maybe you can get your appointment, hopefully...
There is concern, however, that Meta is deprioritizing developers' interests having recently shut down its developer bug portal as well.
This is one of those feels bad moments for the few people dependent on those APIs. But it's hard to feel too bad for developers making tools to market to people on Facebook Groups. Tie your to the whims of a mega-corp, their going to change their product for what's in their best interests and don't own you an explanation.
It is understood that the diagnosis is not of prostate cancer, as some might have incorrectly assumed in light of his separate diagnosis of benign prostate enlargement.
Kind of an important detail is that what type of cancer isn't announced, but it's not prostate cancer. Which isn't great news, since prostate cancer is usually you die with but not from.
Here's a one paragraph ChatGPT summary:
A change in U.S. federal tax law, part of the Tax Cuts and Jobs Act, has impacted American tech companies, especially regarding research and development (R&D). Before 2022, companies could manage their R&D tax bills in two ways: either spreading the cost over five years or writing it off annually. However, since January 1, 2022, all R&D expenses must be spread out over five years. This change has led to unexpected large tax bills for some companies, affecting their finances, causing layoffs, and reducing hiring. Critics say this makes the U.S. less attractive for starting businesses or conducting R&D, especially in tech. Despite efforts to revert these tax changes, there hasn't been much progress in Congress.
"Look! There! Evil!.. pure and simple, total evil from the Eighth Dimension!" -- Buckaroo Banzai
